Anti-leishmanial activity of neolignans from Virola species and synthetic analogues

被引:79
作者
Barata, LES
Santos, LS
Ferri, PH
Phillipson, JD
Paine, A
Croft, SL
机构
[1] Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil
[2] Fed Univ Para, CCEN, Dept Quim, BR-66075110 Belem, Para, Brazil
[3] Univ Fed Goias, Inst Quim & Geociencias, BR-74001970 Goiania, Go, Brazil
[4] Univ London, Sch Pharm, Ctr Pharmacognosy, London WC1N 1AK, England
[5] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
基金
巴西圣保罗研究基金会;
关键词
Virola surinamensis; Virola pavonis; Myristicaceae; Leishmania donovani; beta-ketoethers; beta-ketosulfides; beta-ketoamines; neolignans; anti-leishmanial activity;
D O I
10.1016/S0031-9422(00)00240-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Surinamensin, a neolignan isolated from Virola surinamensis, 3,4,5-trimethoxy-8-[2',6'-dimethoxy-4'-(E)-prophenylphenoxy]phenylpropane, a neolignan isolated from Virola pavonis, and 25 of its synthetic analogues or correlated substances with ether linkages and their corresponding C-8 sulphur and nitrogen analogues, were tested for activity against Leishmania donovani amastigotes and promastigotes in vitro. Some were active against L. donovani promastigotes at 30 muM but inactive against intracellular amastigotes. The natural neolignan from V. pavonis was active against promastigotes at 100 muM. The highest selective activity was found in those compounds with sulphur bridges. The beta -ketosulfide (3,4-dimethoxy)-8-(4'-methylthiophenoxy) produced 42% inhibition of L. donovani amastigotes in the liver of BALB/c mice at 100 mg/kg given once daily for five consecutive days (P > 0.05). (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 25 条
[1]   Recent advances in the fight against leishmaniasis with natural products [J].
Akendengue, B ;
Ngou-Milama, E ;
Laurens, A ;
Hocquemiller, R .
PARASITE, 1999, 6 (01) :3-8
[2]   Antileishmanial activity of compounds extracted and characterized from Centrolobium sclerophyllum [J].
Araujo, CAC ;
Alegrio, LV ;
Leon, LL .
PHYTOCHEMISTRY, 1998, 49 (03) :751-754
[3]   ESTIMATION OF POPULATION AT RISK OF INFECTION AND NUMBER OF CASES OF LEISHMANIASIS [J].
ASHFORD, RW ;
DESJEUX, P ;
DERAADT, P .
PARASITOLOGY TODAY, 1992, 8 (03) :104-105
[4]   NEOLIGNANS OF VIROLA-SURINAMENSIS [J].
BARATA, LES ;
BAKER, PM ;
GOTTLIEB, OR ;
RUVEDA, EA .
PHYTOCHEMISTRY, 1978, 17 (04) :783-786
[5]  
BARATA LES, 1991, 2 BRAZ DTSCH S NAT H, P18
[6]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[7]   ANTILEISHMANIAL ACTIVITY OF LICOCHALCONE A IN MICE INFECTED WITH LEISHMANIA-MAJOR AND IN HAMSTERS INFECTED WITH LEISHMANIA-DONOVANI [J].
CHEN, M ;
CHRISTENSEN, SB ;
THEANDER, TG ;
KHARAZMI, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1339-1344
[8]   SAR ANALYSIS OF SYNTHETIC NEOLIGNANS AND RELATED-COMPOUNDS WHICH ARE ANTI-LEISHMANIASIS ACTIVE COMPOUNDS USING PATTERN-RECOGNITION METHODS [J].
COSTA, MCA ;
BARATA, LES ;
TAKAHATA, Y .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 1995, 340 :185-192
[9]   Conformation of neolignans that bind to the arginine residue in adenosine-kinase from Leishmania donovani [J].
Costa, MCA ;
Barata, LES ;
Takahata, Y .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 1999, 464 (1-3) :281-287
[10]   NEOLIGNANS AND A PHENYLPROPANOID FROM VIROLA-PAVONIS LEAVES [J].
FERRI, PH ;
BARATA, LES .
PHYTOCHEMISTRY, 1992, 31 (04) :1375-1377